Board of Directors of IMCB recommended that dividends be paid for 2025 in the amount of ₽2.8 per ordinary share. The last day of the purchase of securities to receive dividends is June 11, 2026. Dividend yield may amount to 2.29%.

Shareholders of the Moscow International Securities Exchange have decided to increase the authorized capital by placing 3.37 million additional shares through an open subscription. Placement price will be determined later.

IMCB's RAS net profit for 2025 amounted to ₽158.4 million, an increase of 4.8% compared to ₽151.2 million in the previous year. Revenue increased by 8.1% to ₽376.7 million, compared to ₽348.6 million a year earlier.

The management of the biotechnology company Hemabank is currently studying options for an additional placement of ordinary shares through an open subscription. The possible volume of the new issue will reach 3.3 million shares. The final value will be determined later based on the average market indicators of previous trading sessions. The shareholders plan...